Smellie M, Kelland L R, Thurston D E, Souhami R L, Hartley J A
Department of Oncology, UCL Medical School, London, UK.
Br J Cancer. 1994 Jul;70(1):48-53. doi: 10.1038/bjc.1994.248.
The cellular pharmacology of a series of C8-linked pyrrolobenzodiazepine dimers with polymethylene linkers of n = 3-6 (compounds 1-4) has been studied in a range of human tumour cell lines. The four compounds showed the same pattern of relative activity in five ovarian carcinoma cell lines and one cervical carcinoma cell line with the order of IC50 values of 1 < or = 3 < 4 < 2, which correlated with the previously demonstrated DNA interstrand cross-linking ability of the compounds in plasmid DNA. In human leukaemic K562 cells the agents produced a block in the G2/M phase of the cell cycle characteristic of cross-linking drugs, and extensive interstrand cross-linking was observed in cells by alkaline elution with no evidence of single-strand breaks. Cross-links continued to increase up to 24 h following a 1 h exposure to drug, and no repair was evident by 48 h. In a series of ovarian and cervical carcinoma cell lines with acquired resistance to cisplatin no cross-resistance to the most potent compound 1 was observed in two lines whose major mechanism of resistance to cisplatin was reduced platinum transport. Cross-resistance to 1 was observed in a cell line (A2780cisR) possessing elevated glutathione, and depletion of intracellular glutathione using D,L-buthionine-S,R-sulphoximine (BSO) from 10.25 nmol to 2.8 nmol 10(-6) cells reduced the level of resistance from 11-fold to 2-fold compared with sensitive cells. Cross-linking in the resistant cells was restored to 80% of the level in the parent line by BSO pretreatment. There was also a correlation between glutathione levels and sensitivity to 1 measured in several other ovarian cell lines. Compound 1 also showed cross-resistance in the doxorubicin-resistant cell line 41MdoxR and partial cross-resistance in CH1doxR cells. Both these lines possess elevated levels of p170 glycoprotein. Following treatment with 6 microM verapamil, the resistance in these lines decreased almost 2-fold and 8-fold respectively.
已在一系列人类肿瘤细胞系中研究了一系列具有n = 3 - 6的聚亚甲基连接基的C8连接的吡咯并苯二氮卓二聚体(化合物1 - 4)的细胞药理学。这四种化合物在五种卵巢癌细胞系和一种宫颈癌细胞系中表现出相同的相对活性模式,IC50值顺序为1≤3<4<2,这与这些化合物先前在质粒DNA中证明的DNA链间交联能力相关。在人白血病K562细胞中,这些药物使细胞周期阻滞在交联药物特有的G2/M期,通过碱性洗脱在细胞中观察到广泛的链间交联,没有单链断裂的证据。药物暴露1小时后,交联持续增加至24小时,48小时时未见修复。在一系列对顺铂获得性耐药的卵巢和宫颈癌细胞系中,在两个对顺铂的主要耐药机制是铂转运减少的细胞系中,未观察到对最有效的化合物1的交叉耐药。在一个谷胱甘肽水平升高的细胞系(A2780cisR)中观察到对1的交叉耐药,使用D,L-丁硫氨酸-S,R-亚砜胺(BSO)将细胞内谷胱甘肽从10.25 nmol降至2.8 nmol 10(-6)细胞,与敏感细胞相比,耐药水平从11倍降至2倍。通过BSO预处理,耐药细胞中的交联恢复到亲本细胞系水平的80%。在其他几个卵巢细胞系中测量的谷胱甘肽水平与对1的敏感性之间也存在相关性。化合物1在多柔比星耐药细胞系41MdoxR中也表现出交叉耐药,在CH1doxR细胞中表现出部分交叉耐药。这两个细胞系都具有升高的p170糖蛋白水平。用6 microM维拉帕米处理后,这些细胞系中的耐药性分别降低了近2倍和8倍。